img

Global Human Rabies Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Human Rabies Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Rabies Vaccine is an immunization drug used to prevent rabies in people who have been bitten by an animal or otherwise exposed to the rabies virus.
There are a number of rabies vaccines available that are both safe and effective. They can be used to prevent rabies, before or after exposure to the rabies virus, which is commonly caused by a dog bite or a bat bite.
Human Rabies Vaccine report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Human Rabies Vaccine market is projected to reach US$ 1422.9 million in 2034, increasing from US$ 1056 million in 2022, with the CAGR of 4.3% during the period of 2024 to 2034. Demand from Pre-Exposure Vaccine and Post-Exposure Vaccine are the major drivers for the industry.
Global Human Rabies Vaccine market leaders include Chengda Bio, Bharat Biotech, Bavarian Nordic, Sanofi-Pasteur, etc. All of the above hold over 65 percent market share.
Asia-Pacific is the largest consumption area, with a consumption market share close to 60%. Besides, North Americas is the second largest consumption area with a consumption market share of over 15%.
The classification of Human Rabies Vaccine includes Vero Cell, BHK, Chick Embryo Cell, Human Diploid Cells, and Others. In addition, the proportion of Vero Cell rabies vaccines is about 85%.
Human Rabies Vaccine is widely used for Pre-exposure and Post-exposure. The segment of Human Rabies Vaccine used for Post-exposure and the market share is over 70% of the share.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Human Rabies Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Bharat Biotech
Bavarian Nordic
Sanofi-Pasteur
Chengda Bio
KANGH
Prcmise
Henan Grand Biopharma
Zhuoyi Biological
ZhongKe Biopharm
Ningbo Rongan Biological
Indian Immunologicals
Segment by Type
Vero Cell
BHK
Chick Embryo Cell
Human Diploid Cells
Others

Segment by Application


Pre-Exposure Vaccine
Post-Exposure Vaccine

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Human Rabies Vaccine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Human Rabies Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Human Rabies Vaccine industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Human Rabies Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Human Rabies Vaccine introduction, etc. Human Rabies Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Human Rabies Vaccine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Human Rabies Vaccine Market Overview
1.1 Human Rabies Vaccine Product Overview
1.2 Human Rabies Vaccine Market Segment by Type
1.2.1 Vero Cell
1.2.2 BHK
1.2.3 Chick Embryo Cell
1.2.4 Human Diploid Cells
1.2.5 Others
1.3 Global Human Rabies Vaccine Market Size by Type
1.3.1 Global Human Rabies Vaccine Market Size Overview by Type (2018-2034)
1.3.2 Global Human Rabies Vaccine Historic Market Size Review by Type (2018-2024)
1.3.3 Global Human Rabies Vaccine Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Human Rabies Vaccine Sales Breakdown by Type (2018-2024)
1.4.2 Europe Human Rabies Vaccine Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Human Rabies Vaccine Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Human Rabies Vaccine Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Human Rabies Vaccine Sales Breakdown by Type (2018-2024)
2 Global Human Rabies Vaccine Market Competition by Company
2.1 Global Top Players by Human Rabies Vaccine Sales (2018-2024)
2.2 Global Top Players by Human Rabies Vaccine Revenue (2018-2024)
2.3 Global Top Players by Human Rabies Vaccine Price (2018-2024)
2.4 Global Top Manufacturers Human Rabies Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Human Rabies Vaccine Market Competitive Situation and Trends
2.5.1 Human Rabies Vaccine Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Human Rabies Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Rabies Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Human Rabies Vaccine Market
2.8 Key Manufacturers Human Rabies Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Human Rabies Vaccine Status and Outlook by Region
3.1 Global Human Rabies Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Human Rabies Vaccine Historic Market Size by Region
3.2.1 Global Human Rabies Vaccine Sales in Volume by Region (2018-2024)
3.2.2 Global Human Rabies Vaccine Sales in Value by Region (2018-2024)
3.2.3 Global Human Rabies Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Human Rabies Vaccine Forecasted Market Size by Region
3.3.1 Global Human Rabies Vaccine Sales in Volume by Region (2024-2034)
3.3.2 Global Human Rabies Vaccine Sales in Value by Region (2024-2034)
3.3.3 Global Human Rabies Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Human Rabies Vaccine by Application
4.1 Human Rabies Vaccine Market Segment by Application
4.1.1 Pre-Exposure Vaccine
4.1.2 Post-Exposure Vaccine
4.2 Global Human Rabies Vaccine Market Size by Application
4.2.1 Global Human Rabies Vaccine Market Size Overview by Application (2018-2034)
4.2.2 Global Human Rabies Vaccine Historic Market Size Review by Application (2018-2024)
4.2.3 Global Human Rabies Vaccine Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Human Rabies Vaccine Sales Breakdown by Application (2018-2024)
4.3.2 Europe Human Rabies Vaccine Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Human Rabies Vaccine Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Human Rabies Vaccine Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Human Rabies Vaccine Sales Breakdown by Application (2018-2024)
5 North America Human Rabies Vaccine by Country
5.1 North America Human Rabies Vaccine Historic Market Size by Country
5.1.1 North America Human Rabies Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Human Rabies Vaccine Sales in Volume by Country (2018-2024)
5.1.3 North America Human Rabies Vaccine Sales in Value by Country (2018-2024)
5.2 North America Human Rabies Vaccine Forecasted Market Size by Country
5.2.1 North America Human Rabies Vaccine Sales in Volume by Country (2024-2034)
5.2.2 North America Human Rabies Vaccine Sales in Value by Country (2024-2034)
6 Europe Human Rabies Vaccine by Country
6.1 Europe Human Rabies Vaccine Historic Market Size by Country
6.1.1 Europe Human Rabies Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Human Rabies Vaccine Sales in Volume by Country (2018-2024)
6.1.3 Europe Human Rabies Vaccine Sales in Value by Country (2018-2024)
6.2 Europe Human Rabies Vaccine Forecasted Market Size by Country
6.2.1 Europe Human Rabies Vaccine Sales in Volume by Country (2024-2034)
6.2.2 Europe Human Rabies Vaccine Sales in Value by Country (2024-2034)
7 Asia-Pacific Human Rabies Vaccine by Region
7.1 Asia-Pacific Human Rabies Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Human Rabies Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Human Rabies Vaccine Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Human Rabies Vaccine Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Human Rabies Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Human Rabies Vaccine Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Human Rabies Vaccine Sales in Value by Region (2024-2034)
8 Latin America Human Rabies Vaccine by Country
8.1 Latin America Human Rabies Vaccine Historic Market Size by Country
8.1.1 Latin America Human Rabies Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Human Rabies Vaccine Sales in Volume by Country (2018-2024)
8.1.3 Latin America Human Rabies Vaccine Sales in Value by Country (2018-2024)
8.2 Latin America Human Rabies Vaccine Forecasted Market Size by Country
8.2.1 Latin America Human Rabies Vaccine Sales in Volume by Country (2024-2034)
8.2.2 Latin America Human Rabies Vaccine Sales in Value by Country (2024-2034)
9 Middle East and Africa Human Rabies Vaccine by Country
9.1 Middle East and Africa Human Rabies Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Human Rabies Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Human Rabies Vaccine Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Human Rabies Vaccine Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Human Rabies Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Human Rabies Vaccine Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Human Rabies Vaccine Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Bharat Biotech
10.1.1 Bharat Biotech Company Information
10.1.2 Bharat Biotech Introduction and Business Overview
10.1.3 Bharat Biotech Human Rabies Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Bharat Biotech Human Rabies Vaccine Products Offered
10.1.5 Bharat Biotech Recent Development
10.2 Bavarian Nordic
10.2.1 Bavarian Nordic Company Information
10.2.2 Bavarian Nordic Introduction and Business Overview
10.2.3 Bavarian Nordic Human Rabies Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Bavarian Nordic Human Rabies Vaccine Products Offered
10.2.5 Bavarian Nordic Recent Development
10.3 Sanofi-Pasteur
10.3.1 Sanofi-Pasteur Company Information
10.3.2 Sanofi-Pasteur Introduction and Business Overview
10.3.3 Sanofi-Pasteur Human Rabies Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Sanofi-Pasteur Human Rabies Vaccine Products Offered
10.3.5 Sanofi-Pasteur Recent Development
10.4 Chengda Bio
10.4.1 Chengda Bio Company Information
10.4.2 Chengda Bio Introduction and Business Overview
10.4.3 Chengda Bio Human Rabies Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Chengda Bio Human Rabies Vaccine Products Offered
10.4.5 Chengda Bio Recent Development
10.5 KANGH
10.5.1 KANGH Company Information
10.5.2 KANGH Introduction and Business Overview
10.5.3 KANGH Human Rabies Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.5.4 KANGH Human Rabies Vaccine Products Offered
10.5.5 KANGH Recent Development
10.6 Prcmise
10.6.1 Prcmise Company Information
10.6.2 Prcmise Introduction and Business Overview
10.6.3 Prcmise Human Rabies Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Prcmise Human Rabies Vaccine Products Offered
10.6.5 Prcmise Recent Development
10.7 Henan Grand Biopharma
10.7.1 Henan Grand Biopharma Company Information
10.7.2 Henan Grand Biopharma Introduction and Business Overview
10.7.3 Henan Grand Biopharma Human Rabies Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Henan Grand Biopharma Human Rabies Vaccine Products Offered
10.7.5 Henan Grand Biopharma Recent Development
10.8 Zhuoyi Biological
10.8.1 Zhuoyi Biological Company Information
10.8.2 Zhuoyi Biological Introduction and Business Overview
10.8.3 Zhuoyi Biological Human Rabies Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Zhuoyi Biological Human Rabies Vaccine Products Offered
10.8.5 Zhuoyi Biological Recent Development
10.9 ZhongKe Biopharm
10.9.1 ZhongKe Biopharm Company Information
10.9.2 ZhongKe Biopharm Introduction and Business Overview
10.9.3 ZhongKe Biopharm Human Rabies Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.9.4 ZhongKe Biopharm Human Rabies Vaccine Products Offered
10.9.5 ZhongKe Biopharm Recent Development
10.10 Ningbo Rongan Biological
10.10.1 Ningbo Rongan Biological Company Information
10.10.2 Ningbo Rongan Biological Introduction and Business Overview
10.10.3 Ningbo Rongan Biological Human Rabies Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Ningbo Rongan Biological Human Rabies Vaccine Products Offered
10.10.5 Ningbo Rongan Biological Recent Development
10.11 Indian Immunologicals
10.11.1 Indian Immunologicals Company Information
10.11.2 Indian Immunologicals Introduction and Business Overview
10.11.3 Indian Immunologicals Human Rabies Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Indian Immunologicals Human Rabies Vaccine Products Offered
10.11.5 Indian Immunologicals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Human Rabies Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Human Rabies Vaccine Industrial Chain Analysis
11.4 Human Rabies Vaccine Market Dynamics
11.4.1 Human Rabies Vaccine Industry Trends
11.4.2 Human Rabies Vaccine Market Drivers
11.4.3 Human Rabies Vaccine Market Challenges
11.4.4 Human Rabies Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Human Rabies Vaccine Distributors
12.3 Human Rabies Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Vero Cell
Table 2. Major Company of BHK
Table 3. Major Company of Chick Embryo Cell
Table 4. Major Company of Human Diploid Cells
Table 5. Major Company of Others
Table 6. Global Human Rabies Vaccine Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Human Rabies Vaccine Sales by Type (2018-2024) & (K Units)
Table 8. Global Human Rabies Vaccine Sales Market Share in Volume by Type (2018-2024)
Table 9. Global Human Rabies Vaccine Sales by Type (2018-2024) & (US& Million)
Table 10. Global Human Rabies Vaccine Market Share in Value by Type (2018-2024)
Table 11. Global Human Rabies Vaccine Price by Type (2018-2024) & (US$/Unit)
Table 12. Global Human Rabies Vaccine Sales by Type (2024-2034) & (K Units)
Table 13. Global Human Rabies Vaccine Sales Market Share in Volume by Type (2024-2034)
Table 14. Global Human Rabies Vaccine Sales by Type (2024-2034) & (US$ Million)
Table 15. Global Human Rabies Vaccine Sales Market Share in Value by Type (2024-2034)
Table 16. Global Human Rabies Vaccine Price by Type (2024-2034) & (US$/Unit)
Table 17. North America Human Rabies Vaccine Sales by Type (2018-2024) & (K Units)
Table 18. North America Human Rabies Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 19. Europe Human Rabies Vaccine Sales (K Units) by Type (2018-2024)
Table 20. Europe Human Rabies Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 21. Asia-Pacific Human Rabies Vaccine Sales (K Units) by Type (2018-2024)
Table 22. Asia-Pacific Human Rabies Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 23. Latin America Human Rabies Vaccine Sales (K Units) by Type (2018-2024)
Table 24. Latin America Human Rabies Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 25. Middle East and Africa Human Rabies Vaccine Sales (K Units) by Type (2018-2024)
Table 26. Middle East and Africa Human Rabies Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 27. Global Human Rabies Vaccine Sales by Company (2018-2024) & (K Units)
Table 28. Global Human Rabies Vaccine Sales Share by Company (2018-2024)
Table 29. Global Human Rabies Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 30. Global Human Rabies Vaccine Revenue Share by Company (2018-2024)
Table 31. Global Market Human Rabies Vaccine Price by Company (2018-2024) & (US$/Unit)
Table 32. Global Human Rabies Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Human Rabies Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Rabies Vaccine as of 2022)
Table 35. Date of Key Manufacturers Enter into Human Rabies Vaccine Market
Table 36. Key Manufacturers Human Rabies Vaccine Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Human Rabies Vaccine Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 39. Global Human Rabies Vaccine Sales by Region (2018-2024) & (K Units)
Table 40. Global Human Rabies Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 41. Global Human Rabies Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 42. Global Human Rabies Vaccine Sales Market Share in Value by Region (2018-2024)
Table 43. Global Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 44. Global Human Rabies Vaccine Sales by Region (2024-2034) & (K Units)
Table 45. Global Human Rabies Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 46. Global Human Rabies Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 47. Global Human Rabies Vaccine Sales Market Share in Value by Region (2024-2034)
Table 48. Global Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 49. Global Human Rabies Vaccine Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 50. Global Human Rabies Vaccine Sales by Application (2018-2024) & (K Units)
Table 51. Global Human Rabies Vaccine Sales Market Share in Volume by Application (2018-2024)
Table 52. Global Human Rabies Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 53. Global Human Rabies Vaccine Sales Market Share in Value by Application (2018-2024)
Table 54. Global Human Rabies Vaccine Price by Application (2018-2024) & (US$/Unit)
Table 55. Global Human Rabies Vaccine Sales by Application (2024-2034) & (K Units)
Table 56. Global Human Rabies Vaccine Sales Market Share in Volume by Application (2024-2034)
Table 57. Global Human Rabies Vaccine Sales by Application (2024-2034) & (US$ Million)
Table 58. Global Human Rabies Vaccine Sales Market Share in Value by Application (2024-2034)
Table 59. Global Human Rabies Vaccine Price by Application (2024-2034) & (US$/Unit)
Table 60. North America Human Rabies Vaccine Sales by Application (2018-2024) (K Units)
Table 61. North America Human Rabies Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 62. Europe Human Rabies Vaccine Sales by Application (2018-2024) (K Units)
Table 63. Europe Human Rabies Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 64. Asia-Pacific Human Rabies Vaccine Sales by Application (2018-2024) (K Units)
Table 65. Asia-Pacific Human Rabies Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 66. Latin America Human Rabies Vaccine Sales by Application (2018-2024) (K Units)
Table 67. Latin America Human Rabies Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 68. Middle East and Africa Human Rabies Vaccine Sales by Application (2018-2024) (K Units)
Table 69. Middle East and Africa Human Rabies Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 70. North America Human Rabies Vaccine Sales by Country (2018-2024) & (K Units)
Table 71. North America Human Rabies Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 72. North America Human Rabies Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 73. North America Human Rabies Vaccine Sales Market Share in Value by Country (2018-2024)
Table 74. North America Human Rabies Vaccine Sales by Country (2024-2034) & (K Units)
Table 75. North America Human Rabies Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 76. North America Human Rabies Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 77. North America Human Rabies Vaccine Sales Market Share in Value by Country (2024-2034)
Table 78. Europe Human Rabies Vaccine Sales by Country (2018-2024) & (K Units)
Table 79. Europe Human Rabies Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 80. Europe Human Rabies Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 81. Europe Human Rabies Vaccine Sales Market Share in Value by Country (2018-2024)
Table 82. Europe Human Rabies Vaccine Sales by Country (2024-2034) & (K Units)
Table 83. Europe Human Rabies Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 84. Europe Human Rabies Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 85. Europe Human Rabies Vaccine Sales Market Share in Value by Country (2024-2034)
Table 86. Asia-Pacific Human Rabies Vaccine Sales by Region (2018-2024) & (K Units)
Table 87. Asia-Pacific Human Rabies Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 88. Asia-Pacific Human Rabies Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 89. Asia-Pacific Human Rabies Vaccine Sales Market Share in Value by Region (2018-2024)
Table 90. Asia-Pacific Human Rabies Vaccine Sales by Region (2024-2034) & (K Units)
Table 91. Asia-Pacific Human Rabies Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 92. Asia-Pacific Human Rabies Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 93. Asia-Pacific Human Rabies Vaccine Sales Market Share in Value by Region (2024-2034)
Table 94. Latin America Human Rabies Vaccine Sales by Country (2018-2024) & (K Units)
Table 95. Latin America Human Rabies Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 96. Latin America Human Rabies Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 97. Latin America Human Rabies Vaccine Sales Market Share in Value by Country (2018-2024)
Table 98. Latin America Human Rabies Vaccine Sales by Country (2024-2034) & (K Units)
Table 99. Latin America Human Rabies Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 100. Latin America Human Rabies Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 101. Latin America Human Rabies Vaccine Sales Market Share in Value by Country (2024-2034)
Table 102. Middle East and Africa Human Rabies Vaccine Sales by Country (2018-2024) & (K Units)
Table 103. Middle East and Africa Human Rabies Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 104. Middle East and Africa Human Rabies Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 105. Middle East and Africa Human Rabies Vaccine Sales Market Share in Value by Country (2018-2024)
Table 106. Middle East and Africa Human Rabies Vaccine Sales by Country (2024-2034) & (K Units)
Table 107. Middle East and Africa Human Rabies Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 108. Middle East and Africa Human Rabies Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 109. Middle East and Africa Human Rabies Vaccine Sales Market Share in Value by Country (2024-2034)
Table 110. Bharat Biotech Company Information
Table 111. Bharat Biotech Introduction and Business Overview
Table 112. Bharat Biotech Human Rabies Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Bharat Biotech Human Rabies Vaccine Product
Table 114. Bharat Biotech Recent Development
Table 115. Bavarian Nordic Company Information
Table 116. Bavarian Nordic Introduction and Business Overview
Table 117. Bavarian Nordic Human Rabies Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Bavarian Nordic Human Rabies Vaccine Product
Table 119. Bavarian Nordic Recent Development
Table 120. Sanofi-Pasteur Company Information
Table 121. Sanofi-Pasteur Introduction and Business Overview
Table 122. Sanofi-Pasteur Human Rabies Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Sanofi-Pasteur Human Rabies Vaccine Product
Table 124. Sanofi-Pasteur Recent Development
Table 125. Chengda Bio Company Information
Table 126. Chengda Bio Introduction and Business Overview
Table 127. Chengda Bio Human Rabies Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Chengda Bio Human Rabies Vaccine Product
Table 129. Chengda Bio Recent Development
Table 130. KANGH Company Information
Table 131. KANGH Introduction and Business Overview
Table 132. KANGH Human Rabies Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. KANGH Human Rabies Vaccine Product
Table 134. KANGH Recent Development
Table 135. Prcmise Company Information
Table 136. Prcmise Introduction and Business Overview
Table 137. Prcmise Human Rabies Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Prcmise Human Rabies Vaccine Product
Table 139. Prcmise Recent Development
Table 140. Henan Grand Biopharma Company Information
Table 141. Henan Grand Biopharma Introduction and Business Overview
Table 142. Henan Grand Biopharma Human Rabies Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. Henan Grand Biopharma Human Rabies Vaccine Product
Table 144. Henan Grand Biopharma Recent Development
Table 145. Zhuoyi Biological Company Information
Table 146. Zhuoyi Biological Introduction and Business Overview
Table 147. Zhuoyi Biological Human Rabies Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 148. Zhuoyi Biological Human Rabies Vaccine Product
Table 149. Zhuoyi Biological Recent Development
Table 150. ZhongKe Biopharm Company Information
Table 151. ZhongKe Biopharm Introduction and Business Overview
Table 152. ZhongKe Biopharm Human Rabies Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 153. ZhongKe Biopharm Human Rabies Vaccine Product
Table 154. ZhongKe Biopharm Recent Development
Table 155. Ningbo Rongan Biological Company Information
Table 156. Ningbo Rongan Biological Introduction and Business Overview
Table 157. Ningbo Rongan Biological Human Rabies Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 158. Ningbo Rongan Biological Human Rabies Vaccine Product
Table 159. Ningbo Rongan Biological Recent Development
Table 160. Indian Immunologicals Company Information
Table 161. Indian Immunologicals Introduction and Business Overview
Table 162. Indian Immunologicals Human Rabies Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 163. Indian Immunologicals Human Rabies Vaccine Product
Table 164. Indian Immunologicals Recent Development
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Human Rabies Vaccine Market Trends
Table 168. Human Rabies Vaccine Market Drivers
Table 169. Human Rabies Vaccine Market Challenges
Table 170. Human Rabies Vaccine Market Restraints
Table 171. Human Rabies Vaccine Distributors List
Table 172. Human Rabies Vaccine Downstream Customers
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Rabies Vaccine Product Picture
Figure 2. Global Human Rabies Vaccine Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Human Rabies Vaccine Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Human Rabies Vaccine Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Vero Cell
Figure 6. Global Vero Cell Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of BHK
Figure 8. Global BHK Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of Chick Embryo Cell
Figure 10. Global Chick Embryo Cell Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Product Picture of Human Diploid Cells
Figure 12. Global Human Diploid Cells Sales YoY Growth (2018-2034) & (K Units)
Figure 13. Product Picture of Others
Figure 14. Global Others Sales YoY Growth (2018-2034) & (K Units)
Figure 15. Global Human Rabies Vaccine Sales by Type (2018-2034) & (US$ Million)
Figure 16. Global Human Rabies Vaccine Sales Market Share by Type in 2022 & 2034
Figure 17. North America Human Rabies Vaccine Sales Market Share in Volume by Type in 2022
Figure 18. North America Human Rabies Vaccine Sales Market Share in Value by Type in 2022
Figure 19. Europe Human Rabies Vaccine Sales Market Share in Volume by Type in 2022
Figure 20. Europe Human Rabies Vaccine Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific Human Rabies Vaccine Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific Human Rabies Vaccine Sales Market Share in Value by Type in 2022
Figure 23. Latin America Human Rabies Vaccine Sales Market Share in Volume by Type in 2022
Figure 24. Latin America Human Rabies Vaccine Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa Human Rabies Vaccine Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa Human Rabies Vaccine Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Rabies Vaccine Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Rabies Vaccine Revenue in 2022
Figure 29. Human Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Product Picture of Pre-Exposure Vaccine
Figure 31. Global Pre-Exposure Vaccine Sales YoY Growth (2018-2034) & (K Units)
Figure 32. Product Picture of Post-Exposure Vaccine
Figure 33. Global Post-Exposure Vaccine Sales YoY Growth (2018-2034) & (K Units)
Figure 34. Global Human Rabies Vaccine Sales by Application (2018-2034) & (US$ Million)
Figure 35. Global Human Rabies Vaccine Sales Market Share by Application in 2022 & 2034
Figure 36. North America Human Rabies Vaccine Sales Market Share in Volume by Application in 2022
Figure 37. North America Human Rabies Vaccine Sales Market Share in Value by Application in 2022
Figure 38. Europe Human Rabies Vaccine Sales Market Share in Volume by Application in 2022
Figure 39. Europe Human Rabies Vaccine Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Human Rabies Vaccine Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Human Rabies Vaccine Sales Market Share in Value by Application in 2022
Figure 42. Latin America Human Rabies Vaccine Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Human Rabies Vaccine Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Human Rabies Vaccine Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Human Rabies Vaccine Manufacturing Cost Structure
Figure 47. Human Rabies Vaccine Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries